Milacron Files for Secondary Offering

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Milacron Files for Secondary Offering

© Thinkstock

Milacron Holdings Corp. (NYSE: MCRN) has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. No pricing details were given in the filing, but the offering is valued up to $100 million, and the stock most recently closed at $18.72.

No underwriters have been named in this offering yet.

This company is a global leader in the manufacture, distribution and service of highly engineered and customized systems within the plastic technology and processing industry. Milacron is the only global company with a full-line product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment. It maintains strong market positions across these products, as well as leading positions in process control systems, mold bases and components, maintenance, repair and operating (MRO) supplies and fluid technology.

[nativounit]

Milacron has strong brand recognition with products sold in over 100 countries across six continents, and its established and market driven global footprint is well-positioned to benefit from continued robust industry growth in both developed and emerging markets.

Its sales are geographically diversified, with 55% in North America, 19% in Europe, 9% in China, 7% in India and 10% in the rest of the world at the end of 2015, and with 55% in North America, 19% in Europe, 9% in China, 8% in India and 9% in the rest of the world for the nine months ended September 30, 2016.

The breadth of products, long history and global reach have resulted in a large installed base of over 40,000 plastic processing machines and over 140,000 hot runner systems as of December 31, 2015.

In terms of the use of proceeds from this offering, the company detailed in the filing:

The selling stockholders will receive all of the net proceeds from the sale of shares of our common stock offered pursuant to this prospectus, including from any exercise by the underwriters of their option to purchase additional shares. We will not receive any proceeds from the sale of shares of common stock offered pursuant to this prospectus, including from any exercise by the underwriters of their option to purchase additional shares.

Shares of Milacron closed most recently at $18.72, with a consensus analyst price target of $18.29 and a 52-week trading range of $11.56 to $19.32.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

AKAM Vol: 21,556,944
MU Vol: 65,135,624
INTC Vol: 227,504,426
MNST Vol: 15,284,847
DELL Vol: 12,167,525

Top Losing Stocks

MSI Vol: 3,101,643
EXPE Vol: 4,189,786
CTRA Vol: 73,319,495